{"id":956165,"date":"2026-04-29T16:31:07","date_gmt":"2026-04-29T20:31:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/"},"modified":"2026-04-29T16:31:07","modified_gmt":"2026-04-29T20:31:07","slug":"mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/","title":{"rendered":"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>RADNOR, Pa., April  29, 2026  (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the first quarter ended March 31, 2026, after the financial markets close on Wednesday, May 6, 2026.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:45%;width:45%;min-width:45%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong><br \/>\n              <em><br \/>\n                <u>Wednesday, May 6<\/u><br \/>\n              <\/em><br \/>\n            <\/strong><br \/>\n            <sup><br \/>\n              <strong><br \/>\n                <em><br \/>\n                  <u>th<\/u><br \/>\n                <\/em><br \/>\n              <\/strong><br \/>\n            <\/sup><br \/>\n            <strong><br \/>\n              <em><br \/>\n                <u>@ 4:30 p.m. ET<\/u><br \/>\n              <\/em><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"max-width:55%;width:55%;min-width:55%;text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Domestic:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">1-877-704-4453<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">International:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">1-201-389-0920<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Conference ID:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">13759844<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">Webcast:<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1758980&amp;tp_key=c6e146a2dc\" rel=\"nofollow\" target=\"_blank\">Link<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>A live webcast of the conference call may also be found on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7RYB0CnH1plEtxaNx4ZgqKDAWhbl5rEtCML-QVjVbFThSDxseOSVOkli21EgxSSPVZUFdAsBe2TYt_tG3O5spT3rewAlQXuMtgvo72h41PkGdiU4MqHdbHmtGlqYwRVG\" rel=\"nofollow\" target=\"_blank\">News &amp; Events<\/a>\u201d page in the Investor Relations section of the Mineralys Therapeutics website.<\/p>\n<p>\n        <strong>About\u00a0Mineralys Therapeutics<\/strong><br \/>\n        <br \/>Mineralys Therapeutics is a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as CKD, OSA and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dJY5E04BNN1uFb6I0nTxzfxuvXhqtf9l8oe4XiMZ87Hx3vfLIex2zy68xOQyPNpLVOc-aG1VxR8Wbjt1vLJM_UicEUhGeF9pqRt9AXpmlfpLxf47ktUW_sYyFAvrmh4xonYdVY83zCIu5k1rXJi9NUCF42C3oE8paCJPYlbg25dJ60T7il8P5lrNRDqjcyWWDQhl0FYR2Bxc6Zdk2WzJ20Nueabx_xUJ6n2JdcXzxSyUg1eXv24_YIjMwFj9Djwtk8mTZr_sfHA5p4oxvMU1Ug==\" rel=\"nofollow\" target=\"_blank\">https:\/\/mineralystx.com<\/a>. Follow Mineralys on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tSRfa6KC_TXsrCNsVnB1HxE3N0xzrf5kJcFQeZCpUnJMeoVpWKOy1Aid2sQ2zY2fLKLVxMnXTmZKjW2U5-TEwb3wYrSJ483fbIVxUcm9nzMKCZsixyvSd6oQmxK-RAy0xQKHMvQMThRUIPMZnASWoANhcU4WbuRj6SjqjVNr09sDO2surEZMfZIi78pg11cJMaRxqc-05MKyfxG2sqdy_aeZ_HfdlctJdzcsN_Tds20a78DBUd6yPq5RqaMBUdVUpOV5epdzAWftoedBoJbbzpuUTLZiBLb878KGQLWOs2l7DFtVSlm1JoRVaUhKZ-PArjoQE4FiizkRgzneyjYScHfIwRF8vwsrVpcTgzCdWQzK4s5tfu_h3aSxbucOJcERnzcWlZmbGTEnqRTKbkZQyrCcGVw2hKzU7Ui5ZyXkwxRa0NAeEJghYMJpwRETfUKDXaI6V-q7zgbxeNA20VwZjOH2xGD2-m_ZAR74nIMP3MhaJCKTKMXkhcAb8BNfPayLcHrvXLoI9S1EldcCYWddMXqw5Xt98up7ldn7g0OYzhw7CDAgNs_cyYDDe4XyO1HT\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-qS1lMW-F6yozLfvPE8HSprNPEGVZH_vmqLrekd6h0P9qMoHwX7mw_-D-nmz-ApWowiJzVq7rlG4jgwysDR7LPedxpyUDjsi9xurw0zgH0wUK_Ey9kKgTWE_KYyXE3tj-UKVnigldyb26jTc-ip3UjNgSRlGUSrcwX9u1obqTTr0ik09QgwugSzbNWjpADEA-_MVsfX3Bh1N3MIYiSeQHx6kLQpsT4bVlWkpax9TwTM=\" rel=\"nofollow\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EHG22snISRjOk6bJm4q4s8cvVCNQdSaSH0wNVyVlVPD1u0IJAYBdO_NmDs_NDJ1vB5CELlcM-BB8pvtsxhNkmdjXtLAXqdlb6C9z-TwLnZnGJov74G8xqpwW1nYyjEVQJ8xna4fEzOCRwBd4mT9t1Bf2KMCHthnxWnalUspMforRsX4iu2y9LfIBXH2jmeA7hJ_ACWGUPXNcOIKZYXIL8ad3MswXhzmVB7gPRBjd5X7EbzITKGfSK_CG35HoUIE3\" rel=\"nofollow\" target=\"_blank\">Bluesky<\/a>.<\/p>\n<p>\n        <strong>Contact:<br \/><\/strong>Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3z0iNxW-JEzYH-8ArTJxydrTpFYtKVoMzLSu9HWBU_AvyYqQuoSovERt_t7GD1OCG7mBDTPnLbQDl2ySrobdw16Vm37wYvbVH2hlKyZaXZrMM7ErzDAoGC-xW7JhTyj0xRr2oIyOoGliGOKxUSict8n21GLFUHwQDFxhJHXff6Mg_fHFZOF6DYksId2n5qQ9JhYI4urmVmGKPXjmMPLKesy2E9IKv9iENrGyN-06NQTreHMO9ZoQsS-d6FU2CWO5f6EdWa4DKO77VzFH1lMv4MpBfdsU8YqJaWODNqw1CLt6wv8OPw7YosTmP_kzVDY8d8TBAXPtN79cIgMeebXwAeOEubfj0sQ18JMoMbucvzDORj-gQCRaAl5Zhqq9uiIeo5LAkAFrP-QIsY56-uCD5C8Ray2OjoRfnD3rQaslDClVb3LF4IjZGG_l4KTmjBirFaWh59mmaj_5oeHG74TTuesWfl187eR-s_6rJD4U_jmA5URJ_hbgt5kELIU-H9zwIVZ0w3PNf7OTuLrEPj2mCtI3NDxUFdhOHmC580nSNsikX5qMzRjq_Fpa0WnugFnz6P7SE0a8rfcWEUvhouqiyLkQ69VWx4KuXr3aezU-DHmshs2n0ShG_37OcVIEJV4fviojPnSO20sECBml79MvIvJVIw2j7-IgK4eAm9_QpKeP9qkft5obGelHpiY1NtDS5kEx6LrIKuOElMxyyfZYFmeX_ucKvX18m5aTZCBxZuIDElKyFdPC1yP83o8FWsIebdBIgzs9joxrFdpLGVwXcHy75zWK42tCxOPgh6dLDLorYTll2DKQqCJkmjCCpbHTpdsShv_yoae8LdSVbNtlHOv_EmURY5u-wx50kmYVN5w_Qd-YnjxIMgCyCi1U926pFFafComn4Vec-nfeFf0I-0peuZ0sUJUFCMeY96aEgUE=\" rel=\"nofollow\" target=\"_blank\">investorrelations@mineralystx.com<\/a><\/p>\n<p>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>Melyssa Weible<br \/>Elixir Health Public Relations<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rB577wpDQ7jxNxQRxFrrKfF7ZsYbpV0y7OWTZ2819wJQfE8csiO4BOOAcEGR5Gqcgs7mpRLN_ZgEjvODJ61HG9mqtxSl2rMj8gmjNn4AUSTCGppOWroyBEvdaLSzWT9iSv8DE4x-wU5whIaI8tkxjw7xBqnsHC9y4dGYL1LjZ7T5PUKv9Qrq17P_UnTdhbteHQvWxKmpsHGIk6VtH-6YovcdZzTzMWYukUsyJNuxrInipgnB1OJ7gUFDB8xWNcww70hS2SoL97wKq9WZw4fHsnIz2-UICwSgfnlJT6MCtu-g3yNimm9k3JQpr-olq_l4IQ8A5PPICQoxy0e6kOA-5fZ0NvytNBtr7svbVKz1TcHuYV5VEhOYpJH_om3fMA0_hprSY-KetWJHTlIhLdvMso8Q935yCy4rrQGDhw3c8wgpksYlYz3y0aUu_8XlER8Y-yPDGzzdLQ_4MJqzax-J_7oEI44b5V8KYflSYr-GrQ5RQL7l-OwenSliPjBWeO7lDUp3vGclV-xGn-Rd59a48nznUC8b23js5U5T0nodofU=\" rel=\"nofollow\" target=\"_blank\">mweible@elixirhealthpr.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OGU2ZDljMjktYTk4NC00NzU5LWJkYWQtODIzY2ZlOTIxMjFlLTUwMDExMzcwMS0yMDI2LTA0LTI5LWVu\/tiny\/Mineralys-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RADNOR, Pa., April 29, 2026 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the first quarter ended March 31, 2026, after the financial markets close on Wednesday, May 6, 2026. Wednesday, May 6 th @ 4:30 p.m. ET \u00a0 Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13759844 Webcast: Link \u00a0 \u00a0 A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About\u00a0Mineralys Therapeutics Mineralys Therapeutics is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-956165","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa., April 29, 2026 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the first quarter ended March 31, 2026, after the financial markets close on Wednesday, May 6, 2026. Wednesday, May 6 th @ 4:30 p.m. ET \u00a0 Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13759844 Webcast: Link \u00a0 \u00a0 A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About\u00a0Mineralys Therapeutics Mineralys Therapeutics is &hellip; Continue reading &quot;Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-29T20:31:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026\",\"datePublished\":\"2026-04-29T20:31:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/\"},\"wordCount\":210,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/\",\"name\":\"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==\",\"datePublished\":\"2026-04-29T20:31:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/","og_locale":"en_US","og_type":"article","og_title":"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Market Newsdesk","og_description":"RADNOR, Pa., April 29, 2026 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the first quarter ended March 31, 2026, after the financial markets close on Wednesday, May 6, 2026. Wednesday, May 6 th @ 4:30 p.m. ET \u00a0 Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13759844 Webcast: Link \u00a0 \u00a0 A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About\u00a0Mineralys Therapeutics Mineralys Therapeutics is &hellip; Continue reading \"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-29T20:31:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026","datePublished":"2026-04-29T20:31:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/"},"wordCount":210,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/","name":"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==","datePublished":"2026-04-29T20:31:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcwOTcxMSM3NTczNTg3IzUwMDExMzcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=956165"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956165\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=956165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=956165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=956165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}